Skip to main content
. 2019 Jun 17;11(6):833. doi: 10.3390/cancers11060833

Figure 2.

Figure 2

Percentage change in target lesion measurements from baseline. Best Response of the Sum of the Longest Target Lesion Diameters. Patient 10 exhibited new metastatic disease and was removed from the study without measurement of target lesions.